The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients--a European perspective. [electronic resource]
Producer: 20060213Description: 1011-6 p. digitalISSN:- 1368-5031
- Amides
- Antihypertensive Agents -- adverse effects
- Austria
- Bimatoprost
- Chemotherapy, Adjuvant -- economics
- Cloprostenol -- analogs & derivatives
- Cost-Benefit Analysis
- Drug Costs
- Finland
- France
- Glaucoma -- drug therapy
- Humans
- Latanoprost
- Lipids -- adverse effects
- Models, Economic
- Ophthalmic Solutions
- Prostaglandins F, Synthetic -- adverse effects
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.